References
- Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol. 2016;5(1):72–87.
- Powell CR. Not all neurogenic bladders are the same: a proposal for a new neurogenic bladder classification system. Transl Androl Urol. 2016;5(1):12–21.
- Woodbury MG, Hayes KC, Askes HK. Intermittent catheterization practices following spinal cord injury: a national survey. Can J Urol. 2008;15(3):4065–4071.
- Welk B, Lenherr S, Santiago-Lastra Y, et al. Differences in the incidence of urinary tract infections between neurogenic and non-neurogenic bladder dysfunction individuals performing intermittent catheterization. Neurourol Urodyn. 2022;41(4):1002–1011.
- Krebs J, Wöllner J, Pannek J. Risk factors for symptomatic urinary tract infections in individuals with chronic neurogenic lower urinary tract dysfunction. Spinal Cord. 2016;54(9):682–686.
- Krassioukov A, Cragg JJ, West C, et al. The good, the bad and the ugly of catheterization practices among elite athletes with spinal cord injury: a global perspective. Spinal Cord. 2015;53(1):78–82.
- Kennelly M, Thiruchelvam N, Averbeck MA, et al. Adult neurogenic lower urinary tract dysfunction and intermittent catheterisation in a community setting: risk factors model for urinary tract infections. Adv Urol. 2019;2019:2757862–2757862.
- Fisher H, Oluboyede Y, Chadwick T, et al. Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial. Lancet Infect Dis. 2018;18(9):957–968.
- Esclarín De Ruz A, García Leoni E, Herruzo Cabrera R. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol. 2000;164(4):1285–1289.
- Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med. 2002;113(Suppl 1A):67S–79S.
- Wagenlehner FM, Lichtenstern C, Rolfes C, et al. Diagnosis and management for urosepsis. Int J Urol. 2013;20(10):963–970.
- Di Benedetto P. Clean intermittent self-catheterization in neuro-urology. Eur J Phys Rehabil Med. 2011;47(4):651–659.
- Joshi AD, Shukla A, Chawathe V, et al. Clean intermittent catheterization in long-term management of neurogenic bladder in spinal cord injury: patient perspective and experiences. Int J Urol. 2022;29(4):317–323.
- European Association of Urology. Urological infections; 2022. Available from: https://uroweb.org/guidelines/urological-infections/chapter/the-guideline
- Eliakim-Raz N, Babitch T, Shaw E, et al. Risk factors for treatment failure and mortality among hospitalized patients with complicated urinary tract infection: a multicenter retrospective cohort study (RESCUING study group). Clin Infect Dis. 2019;68(1):29–36.
- National Institute for Health and Care Excellence. NICE health technology evaluations: the manual (PMG36). Manchester, UK: National Institute for Health and Care Excellence; 2022.
- Ghislandi S, Apolone G, Garattini L, et al. Is EQ-5D a valid measure of HRQoL in patients with movement disorders? A comparison with SF-36 and FIM questionnaires. Eur J Health Econ. 2002;3(2):125–130.
- Averbeck MA, Krassioukov A, Thiruchelvam N, et al. The impact of different scenarios for intermittent bladder catheterization on health state utilities: results from an internet-based time trade-off survey. J Med Econ. 2018;21(10):945–952.
- Krassioukov A, Igawa Y, Averbeck MA, et al. Gains in health utility associated with urinary catheter innovations. Med Dev. 2018;11:345–351.
- York Health Economics Consortium. Time Trade-Off [online]; 2016. Available from: https://yhec.co.uk/glossary/time-trade-off/
- Lugnér AK, Krabbe PFM. An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health. Expert Rev Pharmacoecon Outcomes Res. 2020;20(4):331–342.
- Savic G, DeVivo MJ, Frankel HL, et al. Long-term survival after traumatic spinal cord injury: a 70-year british study. Spinal Cord. 2017;55(7):651–658.
- Hearn JH, Selvarajah S, Kennedy P, et al. Stigma and self-management: an interpretative phenomenological analysis of the impact of chronic recurrent urinary tract infections after spinal cord injury. Spinal Cord Ser Cases. 2018;4:12.
- Kelly L, Spencer S, Barrett G. Using intermittent self-catheters: experiences of people with neurological damage to their spinal cord. Disabil Rehabil. 2014;36(3):220–226.
- Shaw C, Logan K, Webber I, et al. Effect of clean intermittent self-catheterization on quality of life: a qualitative study. J Adv Nurs. 2008;61(6):641–650.
- Welk B, Myers JB, Kennelly M, et al. A qualitative assessment of psychosocial aspects that play a role in bladder management after spinal cord injury. Spinal Cord. 2021;59(9):978–986.
- Qualtrics; 2022. Available from: https://www.qualtrics.com
- Spinal Injuries Association; 2022. Available from: https://www.spinal.co.uk/
- Bermingham SL, Hodgkinson S, Wright S, et al. Intermittent self catheterisation with hydrophilic, gel reservoir, and non-coated catheters: a systematic review and cost effectiveness analysis. BMJ. 2013;346:e8639.
- Janssen MF, Pickard AS, Golicki D, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717–1727.
- R Core Team. A language and environment for statistical computing; 2022. Available from: https://www.r-project.org/
- Devlin NJ, Shah KK, Feng Y, et al. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018;27(1):7–22.
- Morton F, Nijjar J. Calculating EQ-5D indices and summarising profiles with eq5d. 2023.
- Bermingham SL, Ashe JF. Systematic review of the impact of urinary tract infections on health-related quality of life. BJU Int. 2012;110(11 Pt C):E830–E836.
- Smith AB, Hanbury A, Buesch K. Eliciting health state utilities for aromatic L-amino acid decarboxylase (AADC) deficiency: a UK vignette study. J Patient Rep Outcomes. 2021;5(1):130.
- Smith AB, Hanbury A, Whitty JA, et al. A discrete choice experiment to derive health utilities for aromatic L-Amino acid decarboxylase (AADC) deficiency in France. Patient Relat Outcome Meas. 2022;13:21–30.
- Yang Z, van Busschbach J, Timman R, et al. Logical inconsistencies in time trade-off valuation of EQ-5D-5L health states: whose fault is it? PLoS One. 2017;12(9):e0184883.
- Oppe M, Rand-Hendriksen K, Shah K, et al. EuroQol protocols for time trade-off valuation of health outcomes. Pharmacoeconomics. 2016;34(10):993–1004.
- Sharma S, Brown GC, Brown MM, et al. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol. 2002;86(5):493–496.
- National Institute for Health and Care Excellence. CHTE methods review health-related quality of life task and finish group report; 2020.